Clare F. Malone

821 total citations
10 papers, 487 citations indexed

About

Clare F. Malone is a scholar working on Molecular Biology, Neurology and Cell Biology. According to data from OpenAlex, Clare F. Malone has authored 10 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Cell Biology. Recurrent topics in Clare F. Malone's work include Protein Degradation and Inhibitors (6 papers), Neuroblastoma Research and Treatments (3 papers) and Ubiquitin and proteasome pathways (2 papers). Clare F. Malone is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Neuroblastoma Research and Treatments (3 papers) and Ubiquitin and proteasome pathways (2 papers). Clare F. Malone collaborates with scholars based in United States. Clare F. Malone's co-authors include Karen Cichowski, Ophélia Maertens, Thomas De Raedt, Kay F. Macleod, Marcia C. Haigis, Rachel Ingraham, Valerie S. LeBleu, Brendan D. Manning, Roderick T. Bronson and Kwok‐Kin Wong and has published in prestigious journals such as Nature Cell Biology, Cancer Cell and Cancer Research.

In The Last Decade

Clare F. Malone

10 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clare F. Malone United States 9 302 108 85 85 83 10 487
Renata Sano United States 6 245 0.8× 225 2.1× 66 0.8× 132 1.6× 130 1.6× 8 413
Lynn Bjerke United Kingdom 6 381 1.3× 65 0.6× 56 0.7× 88 1.0× 104 1.3× 8 505
Brooke B. Ancrile United States 7 356 1.2× 162 1.5× 84 1.0× 197 2.3× 106 1.3× 8 749
Janet L. Oblinger United States 14 247 0.8× 155 1.4× 50 0.6× 57 0.7× 76 0.9× 21 456
Jyotidarsini Mohanty United States 7 287 1.0× 67 0.6× 49 0.6× 86 1.0× 36 0.4× 10 421
Barbara Witek Sweden 9 216 0.7× 155 1.4× 36 0.4× 107 1.3× 113 1.4× 11 355
Ana Guerreiro Stücklin Switzerland 15 445 1.5× 208 1.9× 107 1.3× 127 1.5× 121 1.5× 31 774
Max Jacobsen United States 12 257 0.9× 48 0.4× 58 0.7× 68 0.8× 85 1.0× 21 412
Sarah Löw Germany 13 213 0.7× 69 0.6× 152 1.8× 118 1.4× 38 0.5× 16 543
Federica Parodi Italy 12 330 1.1× 121 1.1× 71 0.8× 120 1.4× 164 2.0× 21 566

Countries citing papers authored by Clare F. Malone

Since Specialization
Citations

This map shows the geographic impact of Clare F. Malone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare F. Malone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare F. Malone more than expected).

Fields of papers citing papers by Clare F. Malone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare F. Malone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare F. Malone. The network helps show where Clare F. Malone may publish in the future.

Co-authorship network of co-authors of Clare F. Malone

This figure shows the co-authorship network connecting the top 25 collaborators of Clare F. Malone. A scholar is included among the top collaborators of Clare F. Malone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare F. Malone. Clare F. Malone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Malone, Clare F., Nathaniel W. Mabe, Gabriela Alexe, et al.. (2024). The KAT module of the SAGA complex maintains the oncogenic gene expression program in MYCN- amplified neuroblastoma. Science Advances. 10(22). eadm9449–eadm9449. 4 indexed citations
2.
Mabe, Nathaniel W., Jennifer A. Perry, Clare F. Malone, & Kimberly Stegmaier. (2024). Pharmacological targeting of the cancer epigenome. Nature Cancer. 5(6). 844–865. 27 indexed citations
3.
Lu, Diana, Jana M. Ellegast, Kenneth N. Ross, et al.. (2023). The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma. Nature Cell Biology. 25(2). 285–297. 24 indexed citations
4.
Malone, Clare F., Gabriela Alexe, Amanda L. Robichaud, et al.. (2022). Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors. Cancer Research. 83(2). 285–300. 8 indexed citations
5.
Malone, Clare F., Neekesh V. Dharia, Guillaume Kugener, et al.. (2021). Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer. Cancer Discovery. 11(9). 2282–2299. 23 indexed citations
6.
Malone, Clare F., Rachel Ingraham, William Barbosa, et al.. (2017). mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors. Cancer Discovery. 7(12). 1450–1463. 87 indexed citations
7.
Olsen, Sarah Naomi, Ania Wronski, Zafira Castaño, et al.. (2016). Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discovery. 7(2). 202–217. 52 indexed citations
8.
Malone, Clare F., Jody Fromm Longo, Ophélia Maertens, et al.. (2014). Defining Key Signaling Nodes and Therapeutic Biomarkers in NF1 -Mutant Cancers. Cancer Discovery. 4(9). 1062–1073. 54 indexed citations
9.
Khan, Tahsin, Nathan Benaich, Clare F. Malone, et al.. (2012). Vincristine and bortezomib cause axon outgrowth and behavioral defects in larval zebrafish. Journal of the Peripheral Nervous System. 17(1). 76–89. 12 indexed citations
10.
Raedt, Thomas De, Zandra E. Walton, Jessica L. Yecies, et al.. (2011). Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors. Cancer Cell. 20(3). 400–413. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026